Can spironolactone be used to treat hypertension (HTN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spironolactone for Hypertension Management

Spironolactone is an effective medication for hypertension, particularly as add-on therapy for resistant hypertension, with strong evidence supporting its use as a fourth-line agent when blood pressure remains uncontrolled on three medications including a diuretic. 1

Indications for Spironolactone in Hypertension

Spironolactone is FDA-approved for the treatment of hypertension as add-on therapy to lower blood pressure in patients not adequately controlled on other agents 2. Its use in hypertension management can be categorized as follows:

As Standard Antihypertensive Therapy

  • Classified as a potassium-sparing diuretic in hypertension guidelines 1
  • Considered a secondary agent in the ACC/AHA hypertension guidelines 1
  • Typical dosing range: 25-100 mg daily 1

For Resistant Hypertension

  • Recommended as the fourth-line agent in patients with resistant hypertension after optimizing a three-drug regimen including a diuretic 1
  • Most effective when added to patients whose serum potassium is <4.5 mmol/L and eGFR is >45 ml/min/1.73m² 1
  • Provides significant additional blood pressure reduction (average 21-25/10-12 mmHg) when added to multidrug regimens 3, 4
  • Superior to renal denervation for reducing 24-hour systolic and diastolic blood pressure in resistant hypertension 5

For Primary Aldosteronism

  • Preferred agent for primary aldosteronism 1, 2
  • Particularly effective in bilateral adrenal disease not amenable to surgery 1
  • Effective in patients with resistant hypertension regardless of primary aldosteronism status 3

Dosing Considerations

  • Starting dose: 25 mg daily 1, 2
  • Low doses (12.5-25 mg) can be effective in resistant hypertension 3
  • Can be titrated up to 50-100 mg daily if needed 2, 3
  • Doses greater than 100 mg/day generally do not provide additional blood pressure reduction 2

Monitoring and Precautions

  • Regular monitoring required for:

    • Serum potassium (risk of hyperkalemia)
    • Renal function (can cause acute kidney injury)
    • Side effects (gynecomastia, impotence in men)
  • Contraindications/Cautions:

    • Avoid in patients with significant renal dysfunction (eGFR <45 ml/min) 1
    • Use cautiously with other potassium-sparing medications or potassium supplements 1
    • Avoid in patients with severe bilateral renal artery stenosis 1

Advantages Over Other Agents

  • More effective than other fourth-line agents for resistant hypertension (demonstrated in PATHWAY-2 trial) 1
  • Provides additional benefit even when combined with ACE inhibitors, ARBs, and diuretics 3
  • Beneficial in patients with heart failure with reduced ejection fraction 2
  • Effective in both African American and white patients with resistant hypertension 3

Alternative Options When Spironolactone is Not Tolerated

If spironolactone cannot be used due to side effects or contraindications, alternatives include:

  • Eplerenone (less risk of hormonal side effects but less potent and requires twice-daily dosing) 1
  • Amiloride 1, 6
  • Other options: doxazosin, clonidine, or beta-blockers 1

Clinical Pearls

  • Spironolactone's antihypertensive effect is often seen within 6 weeks of initiation 3
  • The blood pressure-lowering effect persists at 6 months of follow-up 3
  • Consider screening for primary aldosteronism in resistant hypertension before initiating spironolactone 1
  • Newer non-steroidal MRAs (esaxerenone, finerenone) may offer alternatives with fewer side effects in the future 1

Spironolactone remains an underutilized but highly effective option for managing hypertension, particularly in the resistant hypertension setting where it should be considered before more invasive approaches 7, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.